Figure 2From: T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease Changes in estimated glomerular filtration rate between the two treatment groups during the study period. Grey circles: amlodipine group, black circles: benidipine group, mean ± SEM.Back to article page